Bortezomib is a medicine used primarily for the management of two types of blood cancers: multiple myeloma and mantle cell lymphoma. It is a part of the proteasome inhibitors class of medicines.
In some cases, Bortezomib may also be used for the management of other types of cancers as an off-label use.
Nausea
Fatigue
Numbness, tingling, and burning in hands and feet
Low blood platelet count
Low neutrophil count
Bortezomib is recognized as a proteasome inhibitor.
It works by inhibiting proteasomes, complex enzymes within cells that break down and eliminate damaged or unwanted proteins. Cancer cells rely more on proteasomes than healthy cells. By blocking these enzymes, Bortezomib causes a buildup of proteins in cancer cells, leading to their death. This inhibition slows or stops the growth and spread of multiple myeloma and mantle cell lymphoma, effectively managing these types of blood cancers.
Doctor of Medicine
BAMS, APG, PG
Bortezomib is available as a sterile lyophilized powder in single-use vials and is administered either by intravenous or subcutaneous infusion.
Bortezomib is primarily for adults, but Bortezomib may be considered for pediatric patients with certain cancers, subject to the discretion of the treating doctor.
Bortezomib is contraindicated in patients with severe hypersensitivity to Bortezomib, boron or mannitol. Caution should be exercised in patients with pre-existing severe peripheral neuropathy.
Bortezomib may interact with strong inhibitors of the CYP3A4 enzyme (e.g., ketoconazole and ritonavir) and strong inducers of the CYP3A4 enzyme (e.g., rifampin and carbamazepine).
Overdosing on Bortezomib can result in serious adverse effects such as severe peripheral neuropathy and acute kidney injury. Consult your doctor immediately.
If a dose is missed, it should be taken as soon as it is remembered, but not if it is almost time for the next scheduled dose. In such cases, the missed dose should be skipped and the usual dosing schedule resumed.
Most side effects are temporary and generally harmless and resolve when discontinuing Bortezomib. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
Nausea and vomiting can be managed by taking the medication after meals.
Fatigue can be managed by taking rest and maintaining adequate hydration.
Bortezomib may cause dizziness, fatigue, or other side effects that can affect your ability to drive or operate heavy machinery. Avoid such activities if you experience these symptoms.
Bortezomib is not recommended during pregnancy and lactation unless prescribed by your doctor. Consult your doctor before taking this medicine if you are pregnant or breastfeeding.
Patients with existing liver or kidney disease should exercise caution when taking Bortezomib as it may affect liver function and renal function. Caution should also be exercised in patients with existing cardiac conditions as Bortezomib may cause cardiac side effects such as heart failure and abnormal heart rhythms.
Include magnesium-rich foods like spinach, almonds and avocados to help manage potential electrolyte imbalances caused by Bortezomib.
Focus on small, frequent, high-calorie meals to maintain energy levels, especially if experiencing reduced appetite or weight loss.
Frequently asked questions
Hair loss is an uncommon side effect of Bortezomib, affecting less than 10% of patients, so most people do not experience significant hair loss on this medication.
Occasional mood changes, such as feeling very low or experiencing confusion, may occur. In less common cases, you might face memory difficulties, perceive things that aren’t there, or feel anxious or agitated.
Improvement time varies by condition and health factors, and your doctor will monitor your progress closely.
Many people are able to continue working during Bortezomib treatment. However, this depends on the individual's job demands, overall health, and the side effects experienced due to the medication.
The duration of Bortezomib therapy depends on several factors including the type of cancer being managed, the stage of disease, and the patient's response to treatment.
Bortezomib may have an impact on fertility and it is recommended that women of childbearing age and men with female partners use effective contraception during and for some time after Bortezomib treatment.
Bortezomib does not directly impact menstruation. However, the stress and physical changes associated with cancer and its treatment can sometimes affect menstrual cycles in women.
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.16
Our Payment Partners